A pilot study in 19 LGMD patients and one with Becker MD found low-dose prednisone helped lower markers of muscle damage and ...

Company Anticipates Submitting for U.S. Accelerated Approval in H1 2026 -WALTHAM, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, ...

Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 ...

The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular, and metabolic disease indications with a clinical-stage pipeline that ...

When Raniya Scott was just two years old, her world changed with an unexpected diagnosis: Duchenne muscular dystrophy (DMD), ...

Men with SMA are likely to have fertility issues, and patients with more severe motor impairments have lower sperm counts, ...

Learn about the wide-ranging Ecdysozoa group of animals and how scientists solved the curious case of their nervous systems' ...

A decision to approve new medicines to treat Duchenne muscular dystrophy and a rare life-threatening blood disease for use in ...

Mercedes-Benz India launched the EQS SUV 450, priced at ₹1.28 crore featuring a 122 kWh battery and a range of 820 km.

A WHO study found that working 55 or more hours per week increases the risk of stroke by 35 per cent and the risk of dying ...

NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...

The Percheron Therapeutics (ASX:PER) board of directors has written a letter to shareholders following failure of its phase ...